Frederic Fahey

Frederic H. Fahey, ScD

Director, Nuclear Medicine/PET Physics

  • Contact: 617-355-2809

  • Fax: 617-730-0620

Medical Services

Departments

  • Radiology
To schedule an appointment: Call 617-355-2809

Experience and Education

Professional History

Dr. Fahey received his DSc degree in Medical Radiological Physics from Harvard School of Public Health.  He is the Director of Nuclear Medicine/PET Physics at Boston Children’s Hospital and the Director of the BCH Small Animal Imaging Laboratory.  He served as the president of the Society of Nuclear Medicine & Molecular Imaging (SNMMI) in 2012-2013. He has also been awarded Fellow status by the American College of Radiology (ACR) and the American Association of Physicists in Medicine (AAPM).

Publications

Publications powered by Harvard Catalyst Profiles
  1. Zukotynski K, Jadvar H, Capala J, Fahey F. Targeted Radionuclide Therapy: Practical Applications and Future Prospects. Biomark Cancer. 2016; 8(Suppl 2):35-8.
  2. Fahey FH, Ziniel SI, Manion D, Baker A, Treves ST. Administered Activities in Pediatric Nuclear Medicine and the Impact of the 2010 North American Consensus Guidelines on General Hospitals in the United States. J Nucl Med. 2016 Sep; 57(9):1478-85.
  3. Fahey FH, Bom HH, Chiti A, Choi YY, Huang G, Lassmann M, Laurin N, Mut F, Nuñez-Miller R, O'Keeffe D, Pradhan P, Scott AM, Song S, Soni N, Uchiyama M, Vargas L. Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global Standardization. J Nucl Med. 2016 Jul; 57(7):1148-57.
  4. Khamwan K, Plyku D, O'Reilly SE, Goodkind A, Cao X, Fahey FH, Treves ST, Bolch WE, Sgouros G. Pharmacokinetic modeling of [(18)F]fluorodeoxyglucose (FDG) for premature infants, and newborns through 5-year-olds. EJNMMI Res. 2016 Dec; 6(1):28.
  5. Harkness BA, Fahey FH. The Current State of Nuclear Medicine Physics Training: Findings of the AAPM/SNMMI Task Force. J Nucl Med. 2016 Jul; 57(7):1146-7.
  6. O'Reilly SE, Plyku D, Sgouros G, Fahey FH, Ted Treves S, Frey EC, Bolch WE. A risk index for pediatric patients undergoing diagnostic imaging with (99m)Tc-dimercaptosuccinic acid that accounts for body habitus. Phys Med Biol. 2016 Mar 21; 61(6):2319-32.
  7. Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, Sjögreen-Gleisner K, Bolch WE, Brill AB, Fahey F, Fisher DR, Hobbs R, Howell RW, Meredith RF, Sgouros G, Zanzonico P, Bacher K, Chiesa C, Flux G, Lassmann M, Strigari L, Walrand S. MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy. J Nucl Med. 2016 Jan; 57(1):151-62.
  8. Alessio AM, Farrell MB, Fahey FH. Role of Reference Levels in Nuclear Medicine: A Report of the SNMMI Dose Optimization Task Force. J Nucl Med. 2015 Dec; 56(12):1960-4.
  9. Harkness BA, Allison JD, Clements JB, Coffey CW, Fahey FH, Gress DA, Kinahan PE, Nickoloff EL, Mawlawi OR, MacDougall RD, Pizzutiello RJ. AAPM/SNMMI Joint Task Force: report on the current state of nuclear medicine physics training. J Appl Clin Med Phys. 2015; 16(5):5661.
  10. Daly KP, Dearling JL, Seto T, Dunning P, Fahey F, Packard AB, Briscoe DM. Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection. Transplantation. 2015 Sep; 99(9):e132-9.
  11. Show all
  12. Kieran MW, Chi S, Goldman S, Onar-Thomas A, Poussaint TY, Vajapeyam S, Fahey F, Wu S, Turner DC, Stewart CF, Moses M, Packer RJ, Jakacki R, Banerjee A, Boyett JM, Fouladi M, Kun L. A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors. Childs Nerv Syst. 2015 Sep; 31(9):1433-45.
  13. Bartholomä MD, Zhang S, Akurathi V, Pacak CA, Dunning P, Fahey FH, Cowan DB, Treves ST, Packard AB. (18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodamines. Nucl Med Biol. 2015 Oct; 42(10):796-803.
  14. Fahey F. MO-DE-201-03. Med Phys. 2015 Jun; 42(6):3559.
  15. Fahey F, Zukotynski K, Jadvar H, Capala J. Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy. J Nucl Med. 2015 Jul; 56(7):1119-29.
  16. Fahey FH, Ziniel SI, Manion D, Treves ST. Effects of Image Gently and the North American guidelines: administered activities in children at 13 North American pediatric hospitals. J Nucl Med. 2015 Jun; 56(6):962-7.
  17. Fahey F. History Corner: from the new SNMMI historian. J Nucl Med. 2015 Apr; 56(4):11N.
  18. Fahey FH, Bom HH, Chiti A, Choi YY, Huang G, Lassmann M, Laurin N, Mut F, Nuñez-Miller R, O'Keeffe D, Pradhan P, Scott AM, Song S, Soni N, Uchiyama M, Vargas L. Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources. J Nucl Med. 2015 Apr; 56(4):646-51.
  19. Grant FD, Gelfand MJ, Drubach LA, Treves ST, Fahey FH. Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine. Pediatr Radiol. 2015 Apr; 45(5):706-13.
  20. Fahey F, Zukotynski K, Zurakowski D, Markelewicz R, Falone A, Vitello M, Cao X, Grant F, Drubach L, Vija AH, Bhattacharya M, Ding X, Bar-Sever Z, Gelfand M, Treves ST. Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy. Eur J Nucl Med Mol Imaging. 2014 Dec; 41(12):2346-53.
  21. Zukotynski K, Fahey F, Kocak M, Kun L, Boyett J, Fouladi M, Vajapeyam S, Treves T, Poussaint TY. 18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium. J Nucl Med. 2014 Sep; 55(9):1473-80.
  22. Fahey FH, Stabin MG. In any use of ionizing radiation,consideration of the benefits of the exposures to possible risks is a central concern, for the physician and patient. Semin Nucl Med. 2014 May; 44(3):160-1.
  23. Fahey F, Stabin M. Dose optimization in nuclear medicine. Semin Nucl Med. 2014 May; 44(3):193-201.
  24. Treves ST, Falone AE, Fahey FH. Pediatric nuclear medicine and radiation dose. Semin Nucl Med. 2014 May; 44(3):202-9.
  25. Fahey F, Zukotynski K, Capala J, Knight N. Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med. 2014 Feb; 55(2):337-48.
  26. Gururangan S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Fouladi M, Kun LE. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2014 Jan; 16(2):310-7.
  27. Bartholomä MD, He H, Pacak CA, Dunning P, Fahey FH, McGowan FX, Cowan DB, Treves ST, Packard AB. Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracer. Nucl Med Biol. 2013 Nov; 40(8):1043-8.
  28. Markelewicz RJ, Lorenzen WA, Shusterman S, Grant FD, Fahey FH, Treves ST. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy. Clin Nucl Med. 2013 Aug; 38(8):604-7.
  29. Zukotynski KA, Fahey FH, Vajapeyam S, Ng SS, Kocak M, Gururangan S, Kun LE, Poussaint TY. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium. J Nucl Med. 2013 Aug; 54(8):1237-43.
  30. Dearling JL, Barnes JW, Panigrahy D, Zimmerman RE, Fahey F, Treves ST, Morrison MS, Kieran MW, Packard AB. Specific uptake of 99mTc-NC100692, an avß3-targeted imaging probe, in subcutaneous and orthotopic tumors. Nucl Med Biol. 2013 Aug; 40(6):788-94.
  31. Bartholomä MD, Gottumukkala V, Zhang S, Baker A, Dunning P, Fahey FH, Treves ST, Packard AB. Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET). J Med Chem. 2012 Dec 27; 55(24):11004-12.
  32. Fahey FH. Promoting radiation dose optimization. J Nucl Med. 2012 Sep; 53(9):33N.
  33. Drubach LA, Kourmouzi V, Cao X, Zurakowski D, Fahey FH. Gastric emptying in children: what is the best acquisition method? J Pediatr Gastroenterol Nutr. 2012 Aug; 55(2):191-3.
  34. Fahey FH. SNM leadership update: ensuring the health of our profession. J Nucl Med. 2012 Jul; 53(7):22N.
  35. Anderson CJ, Fahey FH, Hunt K. Proposed name change for the society of nuclear medicine. J Nucl Med. 2012 May; 53(5):11N.
  36. Tsai LL, Drubach L, Fahey F, Irons M, Voss S, Ullrich NJ. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. J Neurooncol. 2012 Jul; 108(3):469-75.
  37. Wu LJ, Wu G, Akhavan Sharif MR, Baker A, Jia Y, Fahey FH, Luo HR, Feener EP, Clapham DE. The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke. Nat Neurosci. 2012 Apr; 15(4):565-73.
  38. Fahey FH, Treves ST, Adelstein SJ. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med Technol. 2012 Mar; 40(1):13-24.
  39. Fahey FH. Strengthening our profession through community and collaboration. J Nucl Med. 2012 Feb; 53(2):14N.
  40. Hsiao EM, Cao X, Zurakowski D, Zukotynski KA, Drubach LA, Grant FD, Yahil A, Vija AH, Davis RT, Fahey FH, Treves ST. Reduction in radiation dose in mercaptoacetyltriglycerine renography with enhanced planar processing. Radiology. 2011 Dec; 261(3):907-15.
  41. Shusterman S, Grant FD, Lorenzen W, Davis RT, Laffin S, Drubach LA, Fahey FH, Treves ST. Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: program planning and initial experience. Semin Nucl Med. 2011 Sep; 41(5):354-63.
  42. Routh JC, Grant FD, Kokorowski PJ, Nelson CP, Fahey FH, Treves ST, Lee RS. Economic and radiation costs of initial imaging approaches after a child's first febrile urinary tract infection. Clin Pediatr (Phila). 2012 Jan; 51(1):23-30.
  43. Fahey FH, Treves ST, Adelstein SJ. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med. 2011 Aug; 52(8):1240-51.
  44. Treves ST, Baker A, Fahey FH, Cao X, Davis RT, Drubach LA, Grant FD, Zukotynski K. Nuclear medicine in the first year of life. J Nucl Med. 2011 Jun; 52(6):905-25.
  45. Snay ER, Treves ST, Fahey FH. Improved quality of pediatric 123I-MIBG images with medium-energy collimators. J Nucl Med Technol. 2011 Jun; 39(2):100-4.
  46. Penna FJ, Chow JS, Minnillo BJ, Passerotti CC, Barnewolt CE, Treves ST, Fahey FH, Dunning PS, Freilich DA, Retik AB, Nguyen HT. Identifying ureteropelvic junction obstruction by fluorescence imaging: a comparative study of imaging modalities to assess renal function and degree of obstruction in a mouse model. J Urol. 2011 Jun; 185(6):2405-13.
  47. Zukotynski KA, Fahey FH, Kocak M, Alavi A, Wong TZ, Treves ST, Shulkin BL, Haas-Kogan DA, Geyer JR, Vajapeyam S, Boyett JM, Kun LE, Poussaint TY. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med. 2011 Feb; 52(2):188-95.
  48. Dearling JL, Voss SD, Dunning P, Snay E, Fahey F, Smith SV, Huston JS, Meares CF, Treves ST, Packard AB. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. Nucl Med Biol. 2011 Jan; 38(1):29-38.
  49. Routh JC, Grant FD, Kokorowski P, Lee RS, Fahey FH, Treves ST, Nelson CP. Costs and consequences of universal sibling screening for vesicoureteral reflux: decision analysis. Pediatrics. 2010 Nov; 126(5):865-71.
  50. Stansfield EC, Sheehy N, Zurakowski D, Vija AH, Fahey FH, Treves ST. Pediatric 99mTc-MDP bone SPECT with ordered subset expectation maximization iterative reconstruction with isotropic 3D resolution recovery. Radiology. 2010 Dec; 257(3):793-801.
  51. Dearling JL, Park EJ, Dunning P, Baker A, Fahey F, Treves ST, Soriano SG, Shimaoka M, Packard AB, Peer D. Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody. Inflamm Bowel Dis. 2010 Sep; 16(9):1458-66.
  52. Gelfand MJ, Sharp SE, Treves ST, Fahey FH, Parisi MT, Alessio AM. Estimated cumulative radiation dose from PET/CT in children with malignancies. Pediatr Radiol. 2010 Oct; 40(10):1712-3; author reply 1714-5.
  53. Zhang Z, Wang H, Ikeda S, Fahey F, Bielenberg D, Smits P, Hauschka PV. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis. Am J Pathol. 2010 Sep; 177(3):1459-69.
  54. Fahey FH, Kinahan PE, Doot RK, Kocak M, Thurston H, Poussaint TY. Variability in PET quantitation within a multicenter consortium. Med Phys. 2010 Jul; 37(7):3660-6.
  55. Zukotynski KA, Fahey FH, Laffin S, Davis R, Treves ST, Grant FD, Drubach LA. Seasonal variation in the effect of constant ambient temperature of 24 degrees C in reducing FDG uptake by brown adipose tissue in children. Eur J Nucl Med Mol Imaging. 2010 Oct; 37(10):1854-60.
  56. Drubach LA, Kourmouzi V, Fahey FH. Cheese is a reliable alternative meal for solid-phase gastric emptying study. Nucl Med Commun. 2010 May; 31(5):430-3.
  57. Gottumukkala V, Heinrich TK, Baker A, Dunning P, Fahey FH, Treves ST, Packard AB. Biodistribution and stability studies of [18F]fluoroethylrhodamine B, a potential PET myocardial perfusion agent. Nucl Med Biol. 2010 Apr; 37(3):365-70.
  58. Fahey FH, Abramson ZR, Padwa BL, Zimmerman RE, Zurakowski D, Nissenbaum M, Kaban LB, Treves ST. Use of (99m)Tc-MDP SPECT for assessment of mandibular growth: development of normal values. Eur J Nucl Med Mol Imaging. 2010 May; 37(5):1002-10.
  59. Heinrich TK, Gottumukkala V, Snay E, Dunning P, Fahey FH, Ted Treves S, Packard AB. Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent. Appl Radiat Isot. 2010 Jan; 68(1):96-100.
  60. Fahey FH. Dosimetry of Pediatric PET/CT. J Nucl Med. 2009 Sep; 50(9):1483-91.
  61. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009 Jul 9; 460(7252):259-63.
  62. Sheehy N, Tetrault TA, Zurakowski D, Vija AH, Fahey FH, Treves ST. Pediatric 99mTc-DMSA SPECT performed by using iterative reconstruction with isotropic resolution recovery: improved image quality and reduced radiopharmaceutical activity. Radiology. 2009 May; 251(2):511-6.
  63. Zukotynski KA, Fahey FH, Laffin S, Davis R, Treves ST, Grant FD, Drubach LA. Constant ambient temperature of 24 degrees C significantly reduces FDG uptake by brown adipose tissue in children scanned during the winter. Eur J Nucl Med Mol Imaging. 2009 Apr; 36(4):602-6.
  64. Ward VL, Strauss KJ, Barnewolt CE, Zurakowski D, Venkatakrishnan V, Fahey FH, Lebowitz RL, Taylor GA. Pediatric radiation exposure and effective dose reduction during voiding cystourethrography. Radiology. 2008 Dec; 249(3):1002-9.
  65. Walkley CR, Qudsi R, Sankaran VG, Perry JA, Gostissa M, Roth SI, Rodda SJ, Snay E, Dunning P, Fahey FH, Alt FW, McMahon AP, Orkin SH. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev. 2008 Jun 15; 22(12):1662-76.
  66. Treves ST, Davis RT, Fahey FH. Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America. J Nucl Med. 2008 Jun; 49(6):1024-7.
  67. Williams G, Fahey FH, Treves ST, Kocak M, Pollack IF, Boyett JM, Kun LE, Poussaint TY. Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging. 2008 Sep; 35(9):1651-8.
  68. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008 Jan; 49(1):68-78.
  69. Jadvar H, Connolly LP, Fahey FH, Shulkin BL. PET and PET/CT in pediatric oncology. Semin Nucl Med. 2007 Sep; 37(5):316-31.
  70. Lim R, Fahey FH, Drubach LA, Connolly LP, Treves ST. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain. J Pediatr Orthop. 2007 Apr-May; 27(3):277-82.
  71. Poussaint TY, Phillips PC, Vajapeyam S, Fahey FH, Robertson RL, Osganian S, Ramamurthy U, Mulkern RV, Treves ST, Boyett JM, Kun LE. The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. AJNR Am J Neuroradiol. 2007 Apr; 28(4):603-7.
  72. Fahey FH, Palmer MR, Strauss KJ, Zimmerman RE, Badawi RD, Treves ST. Dosimetry and adequacy of CT-based attenuation correction for pediatric PET: phantom study. Radiology. 2007 Apr; 243(1):96-104.
  73. Fahey FH, Gage HD, Buchheimer N, Smith HC, Harkness BA, Williams RC, Bounds MC, Mercier J, Robbins ME, Payne RM, Morton KA, Mach RH. Evaluation of the quantitative capability of a high-resolution positron emission tomography scanner for small animal imaging. J Comput Assist Tomogr. 2004 Nov-Dec; 28(6):842-8.
  74. Ziessman HA, Fahey FH, Atkins FB, Tall J. Standardization and quantification of radionuclide solid gastric-emptying studies. J Nucl Med. 2004 May; 45(5):760-4.
  75. Fahey FH. Instrumentation in positron emission tomography. Neuroimaging Clin N Am. 2003 Nov; 13(4):659-69.
  76. Fahey FH, Webber RL, Chew FS, Dickerson BA. Application of TACT to the evaluation of total joint arthroplasty. Med Phys. 2003 Mar; 30(3):454-60.
  77. Prielipp RC, Wall MH, Tobin JR, Groban L, Cannon MA, Fahey FH, Gage HD, Stump DA, James RL, Bennett J, Butterworth J. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002 Oct; 95(4):1052-9, table of contents.
  78. Fahey FH, Rhyasen KL, Harkness BA, Meltsner MA, Webber RL. Angular disparity in ETACT scintimammography. Med Phys. 2002 Sep; 29(9):1980-3.
  79. Fahey FH. Data acquisition in PET imaging. J Nucl Med Technol. 2002 Jun; 30(2):39-49.
  80. Fahey FH. Positron emission tomography instrumentation. Radiol Clin North Am. 2001 Sep; 39(5):919-29.
  81. Prielipp RC, Wall MH, Groban L, Tobin JR, Fahey FH, Harkness BA, Stump DA, James RL, Cannon MA, Bennett J, Butterworth J. Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers. Anesth Analg. 2001 Jul; 93(1):45-52.
  82. Fahey FH, Grow KL, Webber RL, Harkness BA, Bayram E, Hemler PF. Emission tuned-aperture computed tomography: a novel approach to scintimammography. J Nucl Med. 2001 Jul; 42(7):1121-7.
  83. Garrett AS, Flowers DL, Absher JR, Fahey FH, Gage HD, Keyes JW, Porrino LJ, Wood FB. Cortical activity related to accuracy of letter recognition. Neuroimage. 2000 Feb; 11(2):111-23.
  84. Fahey FH, Wood FB, Flowers DL, Eades CG, Gage HD, Harkness BA. Evaluation of brain activity in FDG PET studies. J Comput Assist Tomogr. 1998 Nov-Dec; 22(6):953-61.
  85. Ziessman HA, Atkins FB, Vemulakonda US, Tall J, Harkness B, Fahey FH. Lag phase quantification for solid gastric emptying studies. J Nucl Med. 1996 Oct; 37(10):1639-43.
  86. Yu JN, Fahey FH, Gage HD, Eades CG, Harkness BA, Pelizzari CA, Keyes JW. Intermodality, retrospective image registration in the thorax. J Nucl Med. 1995 Dec; 36(12):2333-8.
  87. Graham LS, Fahey FH, Madsen MT, van Aswegen A, Yester MV. Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee. Med Phys. 1995 Apr; 22(4):401-9.
  88. Yu JN, Fahey FH, Harkness BA, Gage HD, Eades CG, Keyes JW. Evaluation of emission-transmission registration in thoracic PET. J Nucl Med. 1994 Nov; 35(11):1777-80.
  89. Fahey FH, Harkness BA, Keyes JW, Madsen MT, Battisti C, Zito V. Sensitivity, resolution and image quality with a multi-head SPECT camera. J Nucl Med. 1992 Oct; 33(10):1859-63.
  90. Ziessman HA, Fahey FH, Collen MJ. Biphasic solid and liquid gastric emptying in normal controls and diabetics using continuous acquisition in LAO view. Dig Dis Sci. 1992 May; 37(5):744-50.
  91. Ziessman HA, Fahey FH, Hixson DJ. Calculation of a gallbladder ejection fraction: advantage of continuous sincalide infusion over the three-minute infusion method. J Nucl Med. 1992 Apr; 33(4):537-41.
  92. Kim HJ, Zeeberg BR, Fahey FH, Hoffman EJ, Reba RC. 3-D SPECT simulations of a complex 3-D mathematical brain model: effects of 3-D geometric detector response, attenuation, scatter, and statistical noise. IEEE Trans Med Imaging. 1992; 11(2):176-86.
  93. Ziessman HA, Silverman PM, Patterson J, Harkness B, Fahey FH, Zeman RK, Keyes JW. Improved detection of small cavernous hemangiomas of the liver with high-resolution three-headed SPECT. J Nucl Med. 1991 Nov; 32(11):2086-91.
  94. Kim HJ, Zeeberg BR, Fahey FH, Bice AN, Hoffman EJ, Reba RC. Three-dimensional SPECT simulations of a complex three-dimensional mathematical brain model and measurements of the three-dimensional physical brain phantom. J Nucl Med. 1991 Oct; 32(10):1923-30.
  95. Cumberlin RL, Rodgers JE, Fahey FH. Digital image processing of radiation therapy portal films. Comput Med Imaging Graph. 1989 May-Jun; 13(3):227-33.
  96. Fahey FH, Ziessman HA, Collen MJ, Eggli DF. Left anterior oblique projection and peak-to-scatter ratio for attenuation compensation of gastric emptying studies. J Nucl Med. 1989 Feb; 30(2):233-9.
  97. Keyes JW, Fahey FH, Harkness BA, Eggli DF, Balseiro J, Ziessman HA. Characterization of the rotating display. Invest Radiol. 1988 Sep; 23(9):692-4.
  98. Goldstein HA, Ziessman HA, Fahey FH, Collea JV, Alijani MR, Helfrich GB. Renal scans in pregnant transplant patients. J Nucl Med. 1988 Aug; 29(8):1364-7.
  99. Ziessman HA, Collen MJ, Fahey FH, Ciarleglio CA, Maher KA, Cattau EL, Fleischer DE, Lewis JH, Benjamin SB. The effect of the Garren-Edwards Gastric Bubble on solid and liquid gastric emptying. Clin Nucl Med. 1988 Aug; 13(8):586-9.
  100. Balseiro J, Fahey FH, Ziessman HA, Le TV. Comparison of bone mineral density in both hips. Radiology. 1988 Apr; 167(1):151-3.
  101. Ziessman HA, Bahar H, Fahey FH, Dubiansky V. Hepatic visualization on iodine-131 whole-body thyroid cancer scans. J Nucl Med. 1987 Sep; 28(9):1408-11.
  102. Ziessman HA, Balseiro J, Fahey FH, Le TV, Dubiansky V. 99mTc-glucoheptonate for quantitation of differential renal function. AJR Am J Roentgenol. 1987 May; 148(5):889-93.
  103. Fahey FH, Zimmerman RE, Judy PF, Lanza RC. Detection efficiency of a high-pressure gas scintillation proportional chamber. Med Phys. 1987 Jan-Feb; 14(1):115-23.
  104. Ziessman HA, Fahey FH, Gochoco JM. Impact of radiocontaminants in commercially available iodine-123: dosimetric evaluation. J Nucl Med. 1986 Mar; 27(3):428-32.
  105. Fahey FH, Zimmerman RE, Judy PF, Lanza RC. Energy resolution in a high-pressure gas scintillation proportional chamber. Med Phys. 1986 Jan-Feb; 13(1):25-34.
  106. Ziessman HA, Fahey FH, Lee TC, Eastman RC, Goldstein HA. Thallium/technetium functional imaging of the thyroid and parathyroid. A case report. Clin Nucl Med. 1985 Dec; 10(12):865-7.
  107. Dreyer NA, Loughlin JE, Fahey FH, Harley NH. The feasibility of epidemiologic studies of cancer in residents near the Rocky Flats Plant. Health Phys. 1982 Jan; 42(1):65-8.
  108. Dreyer NA, Loughlin JE, Friedlander ER, Clapp RW, Fahey FH. Choosing populations to study the health effects of low-dose ionizing radiation. Am J Public Health. 1981 Nov; 71(11):1247-52.
To schedule an appointment: Call 617-355-2809

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close